SCHEMBL10104407

SCHEMBL10104407

Cc1cc(N2CCN(CCF)CC2)c(F)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 2/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR1A P08908 4/20 0.35
ADRA1B P35368 3/20 0.35
ADRB2 P07550 1/20 0.34
CACNA1G O43497 1/20 0.34
GRM2 Q14416 1/20 0.34
HTR2A P28223 3/20 0.33
GNRHR P30968 1/20 0.33
TGFBR1 P36897 1/20 0.33
ACVR1 Q04771 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
PLA2G7 Q13093 1/20 0.33
MGLL Q99685 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104333 0.86 ALDH1A1 (0.42) ALDH1A1
SCHEMBL10104326 0.84 ADRB2 (0.44) ALDH1A1MAPK1HTR1AADRB2HTR2A
SCHEMBL10104400 0.83 PHGDH (0.34) DRD4DRD2DRD3ALDH1A1HTR1A
SCHEMBL10104389 0.81 BRAF (0.38) DRD2DRD3HTR2AHTR2CHTR2B
SCHEMBL10104392 0.81 HTR2A (0.38) ALDH1A1MEN1KMT2AHTR2AHTR2C
SCHEMBL10104401 0.79 HTR2A (0.37) ALDH1A1HTR2AHTR2CHTR2B
SCHEMBL10104332 0.79 ADRB2 (0.40) ALDH1A1ADRB2HTR2AHTR2CHTR2B
SCHEMBL10104394 0.77 HSD11B1 (0.36) ALDH1A1ADRB2HTR2AHTR2CHTR2B
SCHEMBL10104405 0.77 LMNA (0.43) ALDH1A1
SCHEMBL10104391 0.76 ALDH1A1 (0.39) DRD2ALDH1A1HTR1AADRA1BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 DRD4 965/4885DRD2 1976/4885DRD3 1403/4885
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 DRD4 1439/4885DRD2 2798/4885DRD3 873/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 DRD4 1089/4885DRD2 2828/4885DRD3 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.